Total packaging industry deals in Q4 2018 worth $5.44bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 61.6% over the previous quarter and a drop of 40.5% when compared with the last four-quarter average of $9.15bn.

In terms of number of deals, the sector saw a drop of 1.2% over the last four-quarter average with 85 deals against the average of 86 deals.

In value terms, North America led the activity with deals worth $4.14bn.

The top five packaging deals accounted for 72.3% of the overall value in the sector globally during Q4 2018.

Packaging industry deals in Q4 2018: Top deals

The combined value of the top five packaging deals stood at $3.93bn, against the overall value of $5.44bn recorded for the quarter.

The top announced packaging deal tracked by GlobalData in Q4 2018 was Greif’s $1.8bn acquisition of Caraustar Industries,.

In second place was One Madison’s acquisition of Ranpak for $950m and in third place was Oak Hill Capital Partners’ $500m private equity deal with Berlin Packaging,.

Mercer International’s $362.72m acquisition of Daishowa-Marubeni International and Mayr-Melnhof Karton’s acquisition of TANN Group for $317.34m held fourth and fifth positions, respectively.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

Verdict’s parent company GlobalData plc provides business information to 4,000 of the world’s largest companies.

Free Whitepaper How electronic inspection sensors prevented a potentially extremely costly product recall

A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.

Enter your details here to receive your free whitepaper.

Machinery whitepaper

Download our whitepaper

Yes I have read and accept the terms and conditions and privacy policys.


You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our Verdict Privacy Policy to see how we protect and manage your submitted data.

You will receive your free whitepaper after you submit the form.

Close